Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New discovery could pave the way towards therapeutic treatments for many cancers

New discovery could pave the way towards therapeutic treatments for many cancers

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia

International collaboration aims to develop better therapy for childhood acute lymphoblastic leukemia

Study may help refocus research efforts on adolescent and young adult cancer survivorship

Study may help refocus research efforts on adolescent and young adult cancer survivorship

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

Chemotherapy drugs can induce mutations that lead to relapse in pediatric ALL patients

Chemotherapy drugs can induce mutations that lead to relapse in pediatric ALL patients

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Protein markers in chronic lymphocytic leukemia may help determine patients' prognoses

Protein markers in chronic lymphocytic leukemia may help determine patients' prognoses

A drug candidate to prevent adverse reactions due to COVID-19 infection or vaccines

A drug candidate to prevent adverse reactions due to COVID-19 infection or vaccines

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Dying patients with rare diseases struggle to get experimental therapies

Dying patients with rare diseases struggle to get experimental therapies

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Optical genome mapping could change the existing workflow within cytogenetic laboratories

Optical genome mapping could change the existing workflow within cytogenetic laboratories

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Research team identifies a way to improve immune response during viral infections

Research team identifies a way to improve immune response during viral infections

A new study reveals unintended CRISPR/Cas9 editing events

A new study reveals unintended CRISPR/Cas9 editing events

Researchers reveal a promising target for designing anti-cancer therapies

Researchers reveal a promising target for designing anti-cancer therapies

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia